Effect of long-term treatment with azithromycin on disease parameters in cystic fibrosis.
Bowler
Simon D
SD
Dept. of Respiratory Medicine, Mater Adult Hospital, South Brisbane, Australia.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D017963:Azithromycin / Q000008:administration & dosage*; D015415:Biomarkers; D001988:Bronchiolitis / Q000175:diagnosis / Q000188:drug therapy*; D002097:C-Reactive Protein / Q000032:analysis; D003550:Cystic Fibrosis / Q000150:complications*; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D011788:Quality of Life; D016896:Treatment Outcome; D014797:Vital Capacity
D000900:Anti-Bacterial Agents; D015415:Biomarkers; D017963:Azithromycin; D002097:C-Reactive Protein